Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoke Pill
- Development stage
- Unknown
- Lead developer
- Guangzhou Zhong Yi Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xiaoke Pill is a traditional Chinese medicine (TCM) compound formulation used for the treatment of type 2 diabetes mellitus. It is a combination of several Chinese herbal extracts and a low dose of the second-generation sulfonylurea, glibenclamide (also known as glyburide). The drug works by stimulating insulin secretion from pancreatic beta cells via the glibenclamide component, while the herbal components are traditionally used to address the underlying "yin deficiency" and "internal heat" associated with diabetes in TCM theory. Clinical studies, including a large-scale multicenter trial (ChiCTR-TRC-08000074), have shown that Xiaoke Pill provides glycemic control comparable to glibenclamide monotherapy but with a significantly reduced risk of hypoglycemia. It is widely utilized in China as a cost-effective alternative to modern allopathic antidiabetic medications.
- Brand names
- Xiaoke PillXiaoke Wan
- Other names
- 葛蓝消渴丸消渴丸
02
Targets
KATP channel (ATP-sensitive potassium channel)
Beyond the preview
Go deeper on Xiaoke Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaoke Pill.